The DOI matches its Crossref record; 257 of the 257 references it cites were found in a registry or an index.
Sphingolipid metabolism diseases
Open accessAbstract
Human diseases caused by alterations in the metabolism of sphingolipids or glycosphingolipids are mainly disorders of the degradation of these compounds. The sphingolipidoses are a group of monogenic inherited diseases caused by defects in the system of lysosomal sphingolipid degradation, with subsequent accumulation of non-degradable storage material in one or more organs. Most sphingolipidoses are associated with high mortality. Both, the ratio of substrate influx into the lysosomes and the reduced degradative capacity can be addressed by therapeutic approaches. In addition to symptomatic treatments, the current strategies for restoration of the reduced substrate degradation within the lysosome are enzyme replacement therapy (ERT), cell-mediated therapy (CMT) including bone marrow transplantation (BMT) and cell-mediated "cross correction", gene therapy, and enzyme-enhancement therapy with chemical chaperones. The reduction of substrate influx into the lysosomes can be achieved by substrate reduction therapy. Patients suffering from the attenuated form (type 1) of Gaucher disease and from Fabry disease have been successfully treated with ERT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–257 of 257
Brotherus, J. R., & Renkonen, O. (1977) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41698-0 · Cited by 77
Graber, D., Salvayre, R., & Levade, T. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63031060.x · Cited by 76
Martino, S., Marconi, P., Tancini, B., Dolcetta, D., Angelis, M. G. C. D., Montanucci, P., Bregola, G., Sandhoff, K., Bordignon, C., Emiliani, C., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi216 · Cited by 75
Self-citationTreatment of Niemann-Pick disease type B by allogeneic bone marrow transplantation.
Vellodi, A., Hobbs, J. R., O’Donnell, N., Coulter, B. S., & Hugh-Jones, K. (1987) · BMJ · doi:10.1136/bmj.295.6610.1375 · Cited by 74
Ishii, S., Yoshioka, H., Mannen, K., et al. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.07.001 · Cited by 74
Lipid-binding Proteins in Membrane Digestion, Antigen Presentation, and Antimicrobial Defense
Kolter, T., Winau, F., Schaible, U. E., Leippe, M., & Sandhoff, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.r500015200 · Cited by 73
Self-citationSaposin C Is Required for Normal Resistance of Acid β-Glucosidase to Proteolytic Degradation
Sun, Y., Qi, X., & Grabowski, G. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302752200 · Cited by 73
Bone marrow transplantation for infantile ceramidase deficiency (Farber disease)
Yeager, A., Uhas, K. A., Coles, C., Davis, P., Krause, W., & Moser, H. W. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702489 · Cited by 73
Giehl, A., Lemm, T., Bartelsen, O., Sandhoff, K., & Blume, A. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00302.x · Cited by 72
Self-citationEnzyme replacement therapy: conception, chaos and culmination
Brady, R. O. (2003) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2003.1269 · Cited by 72
Möbius, W., Herzog, V., Sandhoff, K., & Schwarzmann, G. O. H. (1999) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549904700804 · Cited by 69
Self-citationSalvayre, R., Douste-Blazy, L., & Gatt, S. (1988) · Springer eBooks · doi:10.1007/978-1-4613-1029-7 · Cited by 69
Transacylase and Phospholipases in the Synthesis of Bis(monoacylglycero)phosphate
Amidon, B., Brown, A., & Waite, M. B. (1996) · Biochemistry · doi:10.1021/bi961164o · Cited by 67
Degradation of Membrane-bound Ganglioside GM2 by β-Hexosaminidase A
Werth, N., Schuette, C. G., Wilkening, G., Lemm, T., & Sandhoff, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007970200 · Cited by 67
Self-citationSchwerer, B. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01550-2 · Cited by 64
Erikson, A., GROTH, C. G., Månsson, J., Percy, A. K., Ringdén, O. T. H., & Svennerholm, L. T. (1990) · Acta Paediatrica · doi:10.1111/j.1651-2227.1990.tb11535.x · Cited by 62
Understanding the Stepwise Synthesis of Glycolipids
Maccioni, H. J. F., Giraudo, C. G., & Daniotti, J. L. (2002) · Neurochemical Research · doi:10.1023/a:1020271932760 · Cited by 61
Meivar‐Levy, I., Horowitz, M., & Futerman, A. H. (1994) · Biochemical Journal · doi:10.1042/bj3030377 · Cited by 61
Effect of Saposins A and C on the Enzymatic Hydrolysis of Liposomal Glucosylceramide
Vaccaro, A. M., Tatti, M., Ciaffoni, F., Salvioli, R., Barca, A., & Scerch, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.16862 · Cited by 60
Metachromatic Leukodystrophy: Recent Research Developments
Gieselmann, V. (2003) · Journal of Child Neurology · doi:10.1177/08830738030180090301 · Cited by 59
SARMIENTOS, F., Schwarzmann, G. O. H., & Sandhoff, K. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb10071.x · Cited by 56
Self-citationChemical Chaperones—A New Concept in Drug Research
Kolter, T., & Wendeler, M. (2003) · ChemBioChem · doi:10.1002/cbic.200390045 · Cited by 55
Self-citationSubstrate reduction therapy for lysosomal storage diseases
Cox, T. M. (2005) · Acta Paediatrica · doi:10.1080/08035320510028157 · Cited by 54
Photoaffinity labelling of the Human GM2‐activator protein
Wendeler, M., Hoernschemeyer, J., Hoffmann, D. E., Kolter, T., Schwarzmann, G., & Sandhoff, K. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2003.03964.x · Cited by 53
Self-citationMouse Models of Human Lysosomal Diseases
Suzuki, K., Proia, R. L., & Suzuki, K. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00145.x · Cited by 51
Zschoche, A., Fürst, W., Schwarzmann, G. O. H., & Sandhoff, K. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18844.x · Cited by 51
Self-citationFinn, L. S., Zhang, M., Chen, S., & Scott, C. R. (2000) · American Journal of Medical Genetics · Cited by 50
Neufeld, E. F. (2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198508786.003.0013 · Cited by 50
Diaz-Font, A., Cormand, B., Santamaria, R., Vilageliu, L., Grinberg, D., & Chabás, A. (2005) · Human Genetics · doi:10.1007/s00439-005-1288-x · Cited by 48 · cited 1×
“A recent work [227] demonstrated a Q430X mutation in the Sap-D-domain on the other allele, so that at least one of the patients is compound heterozygote for Sap-C- and prosaposin deficiency.”
BackgroundDegradation of bis(monoacylglycero)phosphate by an acid phosphodiesterase in rat liver lysosomes.
Matsuzawa, Y., & Hostetler, K. Y. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50510-x · Cited by 48
Fabbro, D., & Grabowski, G. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98580-7 · Cited by 47
Glycosphingolipidoses: Beyond the enzymatic defect
Raas‐Rothschild, A., Pankova-Kholmyansky, I., Kacher, Y., & Futerman, A. H. (2004) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000046272.38480.ef · Cited by 47
Tsuji, D., Kuroki, A., Ishibashi, Y., Itakura, T., Kuwahara, J., Yamanaka, S., & Itoh, K. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.02986.x · Cited by 47
Accumulation of Lysosphingolipids in Tissues from Patients with GM1 and GM2 Gangliosidoses
Kobayashi, T., Goto, I., Okada, S., Orii, T., Ohno, K., & Nakano, T. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08460.x · Cited by 46
Salvioli, R., Tatti, M., Scarpa, S., Moavero, S. M., Ciaffoni, F., Felicetti, F., Kaneski, C. R., Brady, R. O., & Vaccaro, A. M. (2005) · Biochemical Journal · doi:10.1042/bj20050325 · Cited by 45
IL-6 Deficiency Causes Enhanced Pathology in Twitcher (Globoid Cell Leukodystrophy) Mice
Pedchenko, T. V., & LeVine, S. M. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7125 · Cited by 44
Barth, M., Fensom, A. H., & Harris, A. (1993) · Human Genetics · doi:10.1007/bf00230227 · Cited by 44
Slow Progression of Juvenile Metachromatic Leukodystrophy 6 Years After Bone Marrow Transplantation
Kapaun, P., Dittmann, R., Granitzny, B., Eickhoff, W., Wulbrand, H., Neumaier‐Probst, E., Zander, A. R., & Kohlschütter, A. (1999) · Journal of Child Neurology · doi:10.1177/088307389901400402 · Cited by 43
Exocytosis of storage material in a lysosomal disorder
Klein, D., Büssow, H., Fewou, S. N., & Gieselmann, V. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.054 · Cited by 43
Bourgoin, C., Emiliani, C., Kremer, E. J., Gélot, A., Tancini, B., Gravel, R. A., Drugan, C., Orlacchio, A., Poënaru, L., & Caillaud, C. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302081 · Cited by 41
Gene Therapy of Storage Disorders by Retroviral and Lentiviral Vectors
Biffi, A., & Naldini, L. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1133 · Cited by 39
Metachromatic leukodystrophy: consequences of sulphatide accumulation
Gieselmann, V., Franken, S., Klein, D., Je, M., Sandhoff, R., Rauch, R. L., Hartmann, D., Saravanan, V. P. M., Deyn, P. D., D’Hooge, R., et al. (2003) · Acta Paediatrica · doi:10.1111/j.1651-2227.2003.tb00225.x · Cited by 38
Imbalanced substrate specificity of mutant β-galactosidase in patients with Morquio B disease
Okumiya, T., Sakuraba, H., Kase, R., & Sugiura, T. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(02)00199-3 · Cited by 37
Arfı, A., Bourgoin, C., Basso, L., Emiliani, C., Tancini, B., Chigorno, V., Li, Y., Orlacchio, A., Poënaru, L., Sonnino, S., et al. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.04.017 · Cited by 36
Bone marrow transplantation for Niemann‐Pick Type IA disease
Bayever, E., Kamani, N. R., Ferreira, P. C., Machin, G. A., Yudkoff, M., Conard, K. A., Palmieri, M., Radcliffe, J., Wenger, D. A., & August, C. S. (1992) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01800234 · Cited by 35
Tohyama, J., Oya, Y., Ezoe, T., Vanier, M. T., Nakayasu, H., Fujita, N., & Suzuki, K. (1999) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005590316064 · Cited by 34
Storage diseases: new insights into sphingolipid functions
Sillence, D. J., & Platt, F. M. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00033-3 · Cited by 34
What can cell biology tell us about heterogeneity in lysosomal storage diseases?
Gieselmann, V. (2005) · Acta Paediatrica · doi:10.1080/08035320510028210 · Cited by 31
Salvioli, R., Tatti, M., Ciaffoni, F., & Vaccaro, A. M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01417-4 · Cited by 31
An Inducible Mouse Model of Late Onset Tay–Sachs Disease
Jeyakumar, M., Smith, D. A., Eliott-Smith, E., Cortina‐Borja, M., Reinkensmeier, G., Butters, T. D., Lemm, T., Sandhoff, K., Perry, V. H., Dwek, R. A., et al. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0511 · Cited by 30
Self-citationGM1-gangliosidosis (gneralized gangliosidosis). Morphology and chemical pathology.
Suzuki, K., & Gc, C. (1968) · PubMed · Cited by 27
Biomolecule Function: No Reliable Prediction from Cell Culture
Kolter, T., Magin, T. M., & Sandhoff, K. (2000) · Traffic · doi:10.1034/j.1600-0854.2000.011007.x · Cited by 24
Self-citationSosa, M. A. G., Gasperi, R. D., Undevia, S. D., et al. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0136 · Cited by 22
Dvir, H., Harel, M., McCarthy, A. A., Toker, L., Silman, I., Futerman, A. H., & Sussman, J. L. (2003) · Worldwide Protein Data Bank · doi:10.2210/pdb1ogs/pdb · Cited by 19
Primary defects in lysosomal enzymes
WINCHESTER, B. G. (2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198508786.003.0004 · Cited by 15
Cell-mediated delivery systems
Dobrenis, K. (2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198508786.003.00014 · Cited by 13
GM1-ganglioside degradation and biosynthesis in human and murine GM1-gangliosidosis
Sano, R., Trindade, V. M. T., Tessitore, A., d’Azzo, A., Vieira, M. B., Giugliani, R., & Coelho, J. C. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.11.035 · Cited by 11
Cited by
Glycosylation in health and disease
Reily, C., Stewart, T. J., Renfrow, M. B., & Novak, J. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0129-4 · Cited by 2,075
Global reconstruction of the human metabolic network based on genomic and bibliomic data
Duarte, N. C., Becker, S. A., Jamshidi, N., Thiele, I., Mo, M. L., Vo, T. D., Srivas, R., & Palsson, B. Ø. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610772104 · Cited by 1,374
Braulke, T., & Bonifacino, J. S. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.10.016 · Cited by 811
The sphingolipid salvage pathway in ceramide metabolism and signaling
Kitatani, K., Idkowiak-Baldys, J., & Hannun, Y. A. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2007.12.006 · Cited by 632
Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism
Kim, M., Wainwright, H. C., Locketz, M., Bekker, L., Walther, G. B., Dittrich, C., Visser, A., Wang, W., Hsu, F., Wiehart, U., et al. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000079 · Cited by 489
Metadata
- Authors
- Kolter, T., & Sandhoff, K.
- Venue
- Biochimica et Biophysica Acta (BBA) - Biomembranes
- Publisher
- Elsevier BV
- Published
- 2006-12
- Volume
- 1758
- Issue
- 12
- Pages
- 2057-2079
- ISSN
- 0005-2736 (ISSN-L)
- OpenAlex
- W2165980275
- Cited by
- 367
- References
- 257
- FWCI
- 12.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.